טוען...
A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections
Luliconazole is a novel imidazole derivative, which has demonstrated in vitro efficacy against dermatophytes and Candida. The results from Phase III trials show that luliconazole 1% cream applied once daily for 2 weeks successfully resolved the clinical signs and symptoms as well as eradicated the p...
שמור ב:
| הוצא לאור ב: | Infect Drug Resist |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4723097/ https://ncbi.nlm.nih.gov/pubmed/26848272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S61998 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|